Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. AbbVie is running a late-stage cancer study called “An Open-Label, Randomized, Controlled, Global ...
Cases of colon cancer are rising fast, especially in younger adults-and the earliest warning signs are surprisingly easy to ...
Filing acceptance is based on the Phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk by 50% versus chemotherapy alone Nearly one in three patients ...
Immune checkpoint inhibitors (ICIs) have fundamentally transformed the treatment landscape for localized colorectal cancer (CRC), particularly for the mismatch repair-deficient (dMMR) or ...